Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine Citrate for NEC Prevention in Preterm RDS
NCT06097767Phase 1Unknown
- Sponsor
- Al-Azhar University
- Start
- Oct 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of caffeine in necrotizing enterocolitis (NEC) (2 arms), sponsored by Al-Azhar University. Primary endpoint: Incidence of Necrotizing Enterocolitis at 1 year. Status: unknown.
02
Drugs
caffeine
03
Conditions
necrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT06097767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06097767.